Correlation Between Cassava Sciences and INmune Bio
Can any of the company-specific risk be diversified away by investing in both Cassava Sciences and INmune Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cassava Sciences and INmune Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cassava Sciences and INmune Bio, you can compare the effects of market volatilities on Cassava Sciences and INmune Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cassava Sciences with a short position of INmune Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cassava Sciences and INmune Bio.
Diversification Opportunities for Cassava Sciences and INmune Bio
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Cassava and INmune is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Cassava Sciences and INmune Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INmune Bio and Cassava Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cassava Sciences are associated (or correlated) with INmune Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INmune Bio has no effect on the direction of Cassava Sciences i.e., Cassava Sciences and INmune Bio go up and down completely randomly.
Pair Corralation between Cassava Sciences and INmune Bio
Given the investment horizon of 90 days Cassava Sciences is expected to under-perform the INmune Bio. In addition to that, Cassava Sciences is 1.51 times more volatile than INmune Bio. It trades about -0.01 of its total potential returns per unit of risk. INmune Bio is currently generating about 0.0 per unit of volatility. If you would invest 771.00 in INmune Bio on August 30, 2024 and sell it today you would lose (282.00) from holding INmune Bio or give up 36.58% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cassava Sciences vs. INmune Bio
Performance |
| Timeline |
| Cassava Sciences |
| INmune Bio |
Cassava Sciences and INmune Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cassava Sciences and INmune Bio
The main advantage of trading using opposite Cassava Sciences and INmune Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cassava Sciences position performs unexpectedly, INmune Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INmune Bio will offset losses from the drop in INmune Bio's long position.| Cassava Sciences vs. Annovis Bio | Cassava Sciences vs. Axsome Therapeutics | Cassava Sciences vs. Reviva Pharmaceuticals Holdings | Cassava Sciences vs. Seres Therapeutics |
| INmune Bio vs. Tff Pharmaceuticals | INmune Bio vs. Anebulo Pharmaceuticals | INmune Bio vs. AN2 Therapeutics | INmune Bio vs. Cue Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |